Modular Medical, Inc. announced a collaboration under which Phillips-Medisize is providing Modular Medical with design, development and high-volume manufacturing capabilities. Phillips-Medisize leveraged its global, diversified supplier base and deep medical device and diabetes disease experience to design and develop manufacturing and assembly for the MODD1 Insulin Delivery System. Specific expertise provided by Phillips-Medisize included conventional, two-shot and insert injection molding, as well as other services such as packaging, electronics design and manufacturing, and assembly operations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 USD | +3.25% | -10.17% | -12.64% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.64% | 49.27M | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+2.64% | 41.3B | |
+21.98% | 31.6B | |
+16.10% | 25.03B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- MODD Stock
- News Modular Medical, Inc.
- Modular Medical, Inc. Partners with Phillips-Medisize to Expand Insulin Delivery Alternatives